What is he best known for?
The fields of study he is best known for:
Vladimir Tolmachev focuses on Affibody molecule, Cancer research, Molecular imaging, Biodistribution and Pathology.
His Affibody molecule study combines topics from a wide range of disciplines, such as Molecular biology, Phage display and Peptide synthesis.
The study incorporates disciplines such as Nuclear medicine, Antibody, Monoclonal antibody and Trastuzumab in addition to Cancer research.
His Molecular imaging study also includes
- Computational biology and related Nanotechnology, Protein engineering and Molecule,
- Radionuclide imaging which connect with Healthy subjects, Tissue distribution and Knee Joint.
His study in Biodistribution is interdisciplinary in nature, drawing from both Radionuclide therapy, Immunology, Combinatorial chemistry, Oligopeptide and Histidine.
His Pathology research includes themes of Ligand, Receptor, Pet imaging, Positron emission tomography and Breast cancer.
His most cited work include:
- Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. (437 citations)
- Tumor imaging using a picomolar affinity HER2 binding affibody molecule. (414 citations)
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules (222 citations)
What are the main themes of his work throughout his whole career to date?
Vladimir Tolmachev mainly investigates Affibody molecule, Biodistribution, Cancer research, Molecular imaging and In vitro.
The subject of his Affibody molecule research is within the realm of Biochemistry.
Vladimir Tolmachev usually deals with Biodistribution and limits it to topics linked to Biophysics and Molecule and Stereochemistry.
His work in Cancer research addresses issues such as Monoclonal antibody, which are connected to fields such as Antigen.
His Molecular imaging research incorporates themes from Cancer and Breast cancer.
The concepts of his In vitro study are interwoven with issues in Molecular biology and Internalization.
He most often published in these fields:
- Affibody molecule (33.33%)
- Biodistribution (34.30%)
- Cancer research (32.13%)
What were the highlights of his more recent work (between 2018-2021)?
- Biodistribution (34.30%)
- Cancer research (32.13%)
- Molecular imaging (21.01%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Biodistribution, Cancer research, Molecular imaging, In vitro and Affibody molecule.
His Biodistribution study incorporates themes from Cancer cell, Biophysics, Internalization and Pharmacology, Binding selectivity.
Vladimir Tolmachev combines subjects such as Molecular medicine, Targeted therapy, DARPin, Prostate cancer and Monoclonal antibody with his study of Cancer research.
His Molecular imaging research is multidisciplinary, incorporating perspectives in Pet imaging, Breast cancer, Spect imaging and Molecular targets.
The various areas that Vladimir Tolmachev examines in his Affibody molecule study include Contrast, DOTA, Magnetic resonance imaging, Cytotoxic T cell and Receptor expression.
The DOTA study combines topics in areas such as Molecular biology and Receptor–ligand kinetics.
Between 2018 and 2021, his most popular works were:
- Affibody Molecules as Targeting Vectors for PET Imaging (15 citations)
- Affibody Molecules as Targeting Vectors for PET Imaging (15 citations)
- Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties. (13 citations)
In his most recent research, the most cited papers focused on:
Vladimir Tolmachev mostly deals with Biodistribution, Molecular imaging, Cancer research, Biophysics and Scaffold protein.
His Biodistribution research entails a greater understanding of In vitro.
His study on Molecular imaging also encompasses disciplines like
- Binding selectivity which connect with Single-photon emission computed tomography,
- Molecule, which have a strong connection to Pet imaging, Her2 expression and Molecular targets.
His research investigates the connection between Cancer research and topics such as Prostate cancer that intersect with problems in Peptide synthesis, Peptide and Receptor.
His research in Biophysics intersects with topics in Chelation and Affibody molecule.
His research investigates the connection between Affibody molecule and topics such as Trimer that intersect with issues in Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
